Fluorothiazinone for recurrent bladder infections
Treatments studied
Part of Infections, Kidney & urinary clinical trials.
This trial tests an investigational drug called Fluorothiazinone for women with recurring bacterial bladder infections. If you have frequent, painful urinary symptoms, this study might help assess a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman at least 18 years old
- You have a history of recurring bladder infections
- You currently have symptoms like pain, burning, frequent urination, or urgency, scoring 6 or higher on a symptom scale
- You can take oral tablets and are willing to use effective birth control during the study
- You are not pregnant or breastfeeding
- You have not taken certain antibiotics (like nitrofurantoin) within 30 days before the study starts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.
Hear when a new E Coli Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.